Home › Funds › BRAIDWELL LP › ZURA
BRAIDWELL LP position in ZURA
ZURA BIO · Health Care
BRAIDWELL LP reported holding 3,980,295 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$23.5M, representing 0.92% of its reported portfolio and ranking #44 among its reported holdings. BRAIDWELL LP has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BRAIDWELL LP's ZURA position evolved
BRAIDWELL LP first disclosed a stake in ZURA in Q3 2024 at 2,472,806 shares (US$10.0M). The position peaked in Q1 2026 at 3,988,989 shares, worth US$23.7M. Across 8 filings, BRAIDWELL LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 3,980,295 shares valued at US$23.5M. Notable position changes include a 29% increase in Q4 2025 (shares rose 14% over the following quarter), a 25% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.47M | $10.04M | New |
| Q4 2024 | 2.47M | $6.18M | Hold |
| Q1 2025 | 2.47M | $3.19M | Hold |
| Q2 2025 | 2.47M | $2.60M | Hold |
| Q3 2025 | 2.47M | $10.71M | Hold |
| Q4 2025 | 3.18M | $16.67M | Add |
| Q1 2026 | 3.99M | $23.73M | Add |
| Q2 2026 | 3.98M | $23.48M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $55.71M · Q2 2026
- Venrock Adviser, LLC 6.43M sh · $37.97M · Q2 2026
- MPM BioImpact LLC 4.47M sh · $26.39M · Q2 2026
- GREAT POINT PARTNERS LLC 4.22M sh · $24.87M · Q2 2026
- Commodore Capital LP 3.25M sh · $19.18M · Q2 2026
- Saturn V Capital Management LP 2.10M sh · $12.40M · Q2 2026
- QVT Financial LP 1.90M sh · $11.18M · Q2 2026
- ADAR1 Capital Management, LLC 1.76M sh · $10.38M · Q2 2026
- STEMPOINT CAPITAL LP 1.37M sh · $8.07M · Q2 2026
- Ikarian Capital, LLC 1.22M sh · $7.19M · Q2 2026
- EcoR1 Capital, LLC 1.18M sh · $6.96M · Q2 2026
- Boxer Capital Management, LLC 900.00K sh · $5.31M · Q2 2026
More on BRAIDWELL LP
FAQ
How long has BRAIDWELL LP held ZURA?
BRAIDWELL LP has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is BRAIDWELL LP's current position in ZURA?
As of Q2 2026, BRAIDWELL LP holds 3.98M shares of ZURA (ZURA BIO), valued at $23.48M, representing 0.92% of its reported portfolio and ranking #44.
Has BRAIDWELL LP been buying or selling ZURA?
In the latest 13F filing (Q2 2026), BRAIDWELL LP held unchanged its position in ZURA. The position peaked in Q1 2026 at 3.99M shares.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.